| scholarly article | Q13442814 |
| P50 | author | Michael P. Whyte | Q89919619 |
| Steven Mumm | Q95336496 | ||
| William H. McAlister | Q117472672 | ||
| P2093 | author name string | Joanne Kurtzberg | |
| Michelle N Podgornik | |||
| Barbara Waters-Pick | |||
| Paul L Martin | |||
| Alan K Smith | |||
| Lawrence M Ryan | |||
| Stephen P Coburn | |||
| Gary S Gottesman | |||
| Judy Douville | |||
| Cindy R Miller | |||
| R Douglas Armstrong | |||
| P2860 | cites work | Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations | Q39258898 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypophosphatasia | Q1313510 |
| infantile hypophosphatasia | Q32144674 | ||
| P304 | page(s) | 624-36 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Marrow cell transplantation for infantile hypophosphatasia | |
| P478 | volume | 18 |
| Q48631586 | A dimerization defect caused by a glycine substitution at position 420 by serine in tissue-nonspecific alkaline phosphatase associated with perinatal hypophosphatasia |
| Q36778063 | Alkaline Phosphatase and Hypophosphatasia |
| Q44176340 | An asparagine at position 417 of tissue-nonspecific alkaline phosphatase is essential for its structure and function as revealed by analysis of the N417S mutation associated with severe hypophosphatasia |
| Q42002353 | Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration |
| Q50091883 | Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia |
| Q36938338 | Autosomal recessive hypophosphatasia manifesting in utero with long bone deformity but showing spontaneous postnatal improvement |
| Q38025402 | Bone regeneration with mesenchymal stem cells. |
| Q37909967 | Cell therapy in bone healing disorders |
| Q91949725 | Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review |
| Q50674771 | Clinical and genetic aspects of hypophosphatasia in Japanese patients. |
| Q38122364 | Clinical applications of mesenchymal stem cells |
| Q43120980 | Clinical characteristics of perinatal lethal hypophosphatasia: a report of 6 cases |
| Q26775743 | Clinical management of hypophosphatasia |
| Q47862490 | Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia |
| Q33722466 | Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements. |
| Q47762656 | Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis. |
| Q37838864 | Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration |
| Q53130424 | Could Alerting Physicians for Low Alkaline Phosphatase Levels Be Helpful in Early Diagnosis of Hypophosphatasia? |
| Q38134131 | Could mesenchymal stromal cells have a role in childhood autoimmune diseases? |
| Q36528817 | Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation |
| Q37145131 | Dual differentiation-exogenous mesenchymal stem cell therapy for traumatic spinal cord injury repair in a murine hemisection model |
| Q37591306 | ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective |
| Q54715218 | Emerging targeted drug therapies in skeletal dysplasias. |
| Q34008808 | Enzyme replacement therapy for murine hypophosphatasia |
| Q45823959 | Ex Vivo Expanded Allogeneic Mesenchymal Stem Cells With Bone Marrow Transplantation Improved Osteogenesis in Infants With Severe Hypophosphatasia |
| Q45857651 | Gene therapy improves dental manifestations in hypophosphatasia model mice |
| Q38048723 | Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications |
| Q89952405 | Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia |
| Q21202964 | Hypophosphatasia |
| Q38740282 | Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment |
| Q42008004 | Hypophosphatasia - pathophysiology and treatment. |
| Q81718987 | Hypophosphatasia in Taiwan: report of two cases |
| Q83393080 | Hypophosphatasia now draws more attention of both clinicians and researchers: a commentary on Prevalence of c. 1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasias in Japanese and effects of the mutation |
| Q51192993 | Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges. |
| Q38561402 | Hypophosphatasia: an overview of the disease and its treatment |
| Q37895594 | Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). |
| Q34820039 | Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. |
| Q37860414 | Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology |
| Q33719419 | Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus |
| Q26753086 | Mesenchymal stem cells (MSCs) as skeletal therapeutics - an update |
| Q34676808 | Mesenchymal stem cells at the intersection of cell and gene therapy |
| Q37606972 | Mesenchymal stem cells for bone repair and metabolic bone diseases. |
| Q36804672 | Mesenchymal stem cells in bone and cartilage repair: current status |
| Q42133000 | Mesenchymal stem cells: From bench to bedside |
| Q34992277 | Mesenchymal stem cells: Molecular characteristics and clinical applications |
| Q43828726 | Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. |
| Q80937955 | Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis |
| Q41916141 | Osteopoietic engraftment after bone marrow transplantation: effect of inbred strain of mice |
| Q42051018 | Outcome of perinatal hypophosphatasia in manitoba mennonites: a retrospective cohort analysis |
| Q26747780 | Pathophysiology of hypophosphatasia and the potential role of asfotase alfa |
| Q48356405 | Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5'-phosphate availability |
| Q47138648 | Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders |
| Q26852872 | Phosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models |
| Q35807632 | Prevention of Lethal Murine Hypophosphatasia by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow Cells |
| Q57070266 | Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy |
| Q35229937 | Prolonged survival and phenotypic correction of Akp2−/− hypophosphatasia mice by lentiviral gene therapy |
| Q40995186 | Recurrent Metatarsal Fractures in Postmenopausal Woman With Low Serum Alkaline Phosphatase: A Rare Diagnosis Not to Miss |
| Q35575693 | Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase |
| Q45855295 | Restoration of cellular function of mesenchymal stem cells from a hypophosphatasia patient |
| Q90733778 | Suitability and limitations of mesenchymal stem cells to elucidate human bone illness |
| Q34159047 | Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton |
| Q36737833 | Therapeutic potential of mesenchymal stem cells in regenerative medicine |
| Q41900619 | Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment |
| Q92627349 | Update on the management of hypophosphatasia |
| Q83026133 | [Cell therapy in bone-healing disorders] |
| Q80357363 | [The hopes of the mesenchymal stem cells in regenerative medicine] |
Search more.